Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 19, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...

2023-05-19 16:38 2970

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)

- The first plant stem cell-derived exosome patent in the US - The 5th patent allowance following 3 in Korea and 1 in Japan - An important milestone for the global plant stem cell-derived exosome industry SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- ExoCoBio, one of the top three exosome...

2023-05-19 16:34 2963

ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)

Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial

SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue without modifications to move on to the second stage, based on the positive result of the interim...

2023-05-19 16:00 1784

EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden

PARIS, May 19, 2023 /PRNewswire/ -- On May 17th 2023, the six-month result of the SMART Study (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial; NCT02761811) was released on the Late Breaking Clinical Trial conference, reporting ground-breaking findings in the field o...

2023-05-19 14:54 1680

The Seventy-sixth World Health Assembly: Urgent global action to prioritise mental health

LONDON, May 19, 2023 /PRNewswire/ -- As WHO Member States, funders, health practitioners, civil society organisations and businesses engage at the Seventy-sixth World Health Assembly inGeneva, Switzerland from 21st – 30th May, under the theme "WHO at 75: Saving lives, driving health for all", the...

2023-05-19 06:00 2725

Endogenex™ Appoints Christopher Sorli as Chief Medical Officer

Bringing expertise in diabetes management, medical and regulatory affairs, clinical research, and market access MINNEAPOLIS, May 18, 2023 /PRNewswire/ -- Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition ofChristopher Sorli, M.D., Ph.D., as Chief Medical...

2023-05-18 22:00 2926

HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics

CHENGDU, China, May 18, 2023 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) announced today that it has entered into a research agreement with ARase Therapeutics, Inc. ("ARase"), a biotechnology company developing first-in-class therapeutics targetin...

2023-05-18 21:30 2166

The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China.

CHENGDU, China, May 18, 2023 /PRNewswire/ -- On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (Sf9 cells) developed by WestVac Biopharma/ West China Medical Center,Sichuan University against the most recent cir...

2023-05-18 21:23 4090

The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China.

Neurophet receives FDA 510(k) Clearance for Neurophet AQUA

- Flagship products Neurophet AQUA and Neurophet SCALE PET both received 510k - Plans to cooperate with radiology AI solution platform companies to enter the U.S. market SEOUL, South Korea, May 18, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease...

2023-05-18 21:00 1917

Neurophet receives FDA 510(k) Clearance for Neurophet AQUA

CARsgen Initiates Phase 2 Clinical Trial for CLDN18.2 CAR T-cell Product CT041 in the U.S.

SHANGHAI, May 18, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that CARsgen has initiated patient enrollment for Phase 2 of the clinic...

2023-05-18 20:50 2151

YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023

GAITHERSBURG, Md., May 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...

2023-05-18 20:25 3761

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

SAN DIEGO, May 18, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing services, today announced leadership changes at the company's site inSan Diego, effective immediately. Bert Barbosa has ...

2023-05-18 20:05 2352

DISCOVERY LIFE SCIENCES JOINS AKOYA BIOSCIENCES' GLOBAL SERVICE PROVIDER NETWORK TO ACCELERATE IMMUNO-ONCOLOGY RESEARCH

HUNTSVILLE, Ala., May 18, 2023 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, announced today that it has officially qualified as one of Akoya Biosciences' global service providers. The qualification process evaluated Discovery's proficiency in ...

2023-05-18 20:05 2544

AIA Hong Kong to launch market-first critical illness product "AIA Assemble"

New offering enables customers to select different types of critical illness coveraccording to personal needs and budget Enjoy up to a four-month premium refund and free HPV vaccination offer during the promotional period Singer/ songwriter Terence Lam stars in a new ad to share his perso...

2023-05-18 17:54 2061

Top-quality medical grade TPUs enabled by smart factory: ICP DAS - BMP to exhibit at Medtec China 2023

HSINCHU, May 18, 2023 /PRNewswire/ -- Smart manufacturing & stringent process control enhance TPU quality. ICP DAS - BMP (Biomedical Polymers), aTaiwan-based supplier of medical-grade TPU (thermoplastic polyurethane), acts as a front-runner who deploys IIoT systems in a smart factory to maintain ...

2023-05-18 17:02 2744

Top-quality medical grade TPUs enabled by smart factory: ICP DAS - BMP to exhibit at Medtec China 2023

CPIC Continuously Improving the Construction of the "Insurance + Service" Ecosystem to Safeguard a Better Life for Residents

HONG KONG, May 18, 2023 /PRNewswire/ -- Medical insurance is an inevitable result of social progress and economic development. It not only provides the most important protection for hospitalization and outpatient reimbursement for serious illnesses, but also serves as the last line of defense for...

2023-05-18 16:38 3612

Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

SHANGHAI, May 18, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced a strategic collaboration with UroViu C...

2023-05-18 16:00 1918

Malaysia Healthcare Travel Council Expands Global Reach

Strategic Partnerships with Passage Asia and Ezy Healthcare Propel Malaysia's Healthcare Travel Industry to New Heights KUALA LUMPUR, Malaysia, May 18, 2023 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) has further strengthened its global presence with the signing of two strategic Me...

2023-05-18 14:28 2364

Malaysia Healthcare Travel Council Expands Global Reach

Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 /PRNewswi...

2023-05-18 14:00 3321

Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031

* ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncologyand Antengene's third drug candidate to enter clinical studies in the U.S. * The Phase I "PERFORM" study will evaluate the safety and tolerability, pharmacolo...

2023-05-18 11:53 2881

1 ... 154 155 156157158 159 160 ... 808